rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1996-11-25
|
pubmed:abstractText |
Patients having cardiac operations often require blood transfusions. Aprotinin reduces the need for blood transfusions during coronary artery bypass graft operations. To determine the safety and effectiveness of aprotinin in reducing the use of allogeneic blood and postoperative mediastinal chest tube drainage, we studied 212 patients undergoing primary sternotomy for valve replacement or repair.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-5223
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1081-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8873736-Aprotinin,
pubmed-meshheading:8873736-Blood Loss, Surgical,
pubmed-meshheading:8873736-Blood Transfusion,
pubmed-meshheading:8873736-Chest Tubes,
pubmed-meshheading:8873736-Double-Blind Method,
pubmed-meshheading:8873736-Drainage,
pubmed-meshheading:8873736-Erythrocyte Volume,
pubmed-meshheading:8873736-Female,
pubmed-meshheading:8873736-Heart Valves,
pubmed-meshheading:8873736-Hemoglobins,
pubmed-meshheading:8873736-Hemostatics,
pubmed-meshheading:8873736-Humans,
pubmed-meshheading:8873736-Kidney,
pubmed-meshheading:8873736-Male,
pubmed-meshheading:8873736-Middle Aged,
pubmed-meshheading:8873736-Prospective Studies
|
pubmed:year |
1996
|
pubmed:articleTitle |
Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.
|
pubmed:affiliation |
Department of Anesthesia, Massachusetts General Hospital, Boston 02114-2696, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|